Unravelling Insights into the Evolution and Management of SARS-CoV-2

Unravelling Insights into the Evolution and Management of SARS-CoV-2

Worldwide, the COVID-19 pandemic, caused by the brand-new coronavirus SARS-CoV-2, has claimed a sizable number of lives. The virus’ rapid spread and impact on every facet of human existence necessitate a continuous and dynamic examination of its biology and management. Despite this urgency, COVID-19...

Full description

Bibliographic Details
Main Authors:	Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene B. Khan, Hezekiel M. Kumalo
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	BioMedInformatics
Subjects:	SARS-CoV-2 COVID-19 mutations vaccines therapeutics drug repurposing
Online Access:	https://www.mdpi.com/2673-7426/4/1/22

Similar Items

A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
by: Aganze Gloire-Aimé Mushebenge, et al.
Published: (2023-09-01)

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
by: Aganze Gloire-Aimé Mushebenge, et al.
Published: (2023-10-01)

Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation
by: Aganze G. Mushebenge, et al.
Published: (2023-03-01)

Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus
by: Samuel C. Ugbaja, et al.
Published: (2022-07-01)

Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
by: Samuel C. Ugbaja, et al.
Published: (2022-07-01)

Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex
by: Sphamandla E. Mtambo, et al.
Published: (2022-03-01)

Mapping evidence of the concomitant management of schistosomiasis by traditional health practitioners and health care professionals in communities with high prevalent infections: a systematic scoping review protocol
by: Gloire-Aimé Aganze Mushebenge, et al.
Published: (2019-07-01)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
by: Dale J. Calleja, et al.
Published: (2022-04-01)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS
by: Neli Korsun, et al.
Published: (2022-02-01)

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus
by: Sphamandla E. Mtambo, et al.
Published: (2022-07-01)

Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
by: Sabyasachi Dash, et al.
Published: (2021-09-01)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023-07-01)

Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
by: Luis C. Vesga, et al.
Published: (2022-04-01)

Evidence on collaboration of traditional and biomedical practitioners in the management of antimicrobial resistance in sub-Saharan Africa over 15 years: a systematic review protocol
by: Aganze Gloire-Aimé Mushebenge, et al.
Published: (2021-05-01)

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
by: Jennifer Santos, et al.
Published: (2020-06-01)

Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
by: Atsushi Hijikata, et al.
Published: (2022-01-01)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
by: Seri Jo, et al.
Published: (2021-04-01)

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
by: Javed Akhter, et al.
Published: (2021-03-01)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
by: Ashour NA, et al.
Published: (2022-03-01)

Aptamers as Insights for Targeting SARS-CoV-2
by: Suna Karadeniz Saygılı, et al.
Published: (2023-05-01)

Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages
by: Varsha Ravi, et al.
Published: (2024-01-01)

SARS-CoV2 Infection and the Importance of Potassium Balance
by: Helen C. Causton
Published: (2021-10-01)

Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction
by: Sefer BADAY
Published: (2021-08-01)

In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
by: Maria I. Zapata-Cardona, et al.
Published: (2023-01-01)

Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection
by: Alexander J. McAuley, et al.
Published: (2022-10-01)

Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, Zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2
by: Deeptimayee Rout, et al.
Published: (2023-12-01)

Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
by: Estefanía Calvo-Alvarez, et al.
Published: (2022-06-01)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
by: Miguel Angel Martinez
Published: (2022-02-01)

Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences
by: Bechara Abouarab, et al.
Published: (2023-09-01)

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective
by: Sphamandla E. Mtambo, et al.
Published: (2022-03-01)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
by: Canrong Wu, et al.
Published: (2020-05-01)

Prospective mode of action of Ivermectin: SARS-CoV-2
by: Vaishali M. Patil, et al.
Published: (2022-04-01)

Atlas of interactions between SARS-CoV-2 macromolecules and host proteins
by: Guangnan Li, et al.
Published: (2023-02-01)

Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity
by: Serge Mignani, et al.
Published: (2021-09-01)

Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From in silico to in vitro Validation
by: Rajaiah Alexpandi, et al.
Published: (2022-05-01)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
by: Amal Mahmoud, et al.
Published: (2021-09-01)

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
by: Wen Jiang, et al.
Published: (2022-07-01)

Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing
by: Letizia Bernardo, et al.
Published: (2023-08-01)

FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
by: Mahmoud S. Ahmed, et al.
Published: (2023-06-01)